drugset / Trial / NCT04390971
Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia
Completed
3 enrolled
Institute of Hematology & Blood Diseases Hospital, China
EdiGene Inc. · collabThe Affiliated Hospital Of Guizhou Medical University · collabZunyi Medical College · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, multi-center study to evaluate the safety and Efficacy of ET-01 Transplantation in subjects with Transfusion Dependent β-Thalassaemia.
Timeline
- Start
- 2023-02-10
- Primary completion
- 2023-03-05
- Completion
- 2023-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Intravenous |